Meeting
2021 ASCO Annual Meeting
Genomic immunotherapy (IO) biomarkers detected on comprehensive genomic profiling (CGP) of tissue and circulating tumor DNA (ctDNA).
Authors
Takayuki Yoshino
National Cancer Center Hospital East, Kashiwa, Japan
Takayuki Yoshino , Hanna Tukachinsky , Jessica Kim Lee , Ethan Sokol , Dean C. Pavlick , Aparna Aiyer , David Fabrizio , Jeffrey Michael Venstrom , Saori Mishima , Yoshiaki Nakamura , Geoffrey R. Oxnard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 2541)
DOI
10.1200/JCO.2021.39.15_suppl.2541
Abstract #
2541
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Gynecologic-cancer analysis of ARID1A alterations detected in tissue and liquid biopsies.
First Author: Natalie Danziger
Poster
2022 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status.
First Author: Gennady Bratslavsky
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Does detection of microsatellite instability-high (MSI-H) by plasma-based testing predict tumor response to immunotherapy (IO) in patients with pancreatic cancer (PC)?
First Author: Sakti Chakrabarti
Poster
2021 Genitourinary Cancers Symposium
Tumor mutation burden and immune microenvironment analysis of urothelial carcinoma.
First Author: Yuanyuan Jia